Guangzhou Wondfo Biotech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 23.76%

Guangzhou Wondfo Biotech Co Ltd (300482) has an Asset Resilience Ratio of 23.76% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.60 Billion

≈ $234.11 Million USD Cash + Short-term Investments

Total Assets

CN¥6.73 Billion

≈ $985.42 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Guangzhou Wondfo Biotech Co Ltd's Asset Resilience Ratio has changed over time. Check 300482 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Wondfo Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Guangzhou Wondfo Biotech Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.60 Billion	23.76%
Total Liquid Assets	CN¥1.60 Billion	23.76%

Asset Resilience Insights

Good Liquidity Position: Guangzhou Wondfo Biotech Co Ltd maintains a healthy 23.76% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Guangzhou Wondfo Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangzhou Wondfo Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Guangzhou Wondfo Biotech Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Wondfo Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	19.15%	CN¥1.26 Billion ≈ $185.03 Million	CN¥6.60 Billion ≈ $966.03 Million	+0.90pp
2024-12-31	18.26%	CN¥1.31 Billion ≈ $191.15 Million	CN¥7.15 Billion ≈ $1.05 Billion	+5.74pp
2023-12-31	12.52%	CN¥722.45 Million ≈ $105.72 Million	CN¥5.77 Billion ≈ $844.58 Million	-2.37pp
2022-12-31	14.89%	CN¥938.07 Million ≈ $137.27 Million	CN¥6.30 Billion ≈ $922.05 Million	+3.09pp
2021-12-31	11.79%	CN¥572.73 Million ≈ $83.81 Million	CN¥4.86 Billion ≈ $710.56 Million	+9.41pp
2020-12-31	2.38%	CN¥102.60 Million ≈ $15.01 Million	CN¥4.31 Billion ≈ $630.12 Million	-1.00pp
2019-12-31	3.38%	CN¥99.50 Million ≈ $14.56 Million	CN¥2.94 Billion ≈ $430.80 Million	+4.04pp
2018-12-31	-0.66%	CN¥-17.66 Million ≈ $-2.58 Million	CN¥2.69 Billion ≈ $393.85 Million	+2.28pp
2017-12-31	-2.94%	CN¥-49.75 Million ≈ $-7.28 Million	CN¥1.69 Billion ≈ $248.00 Million	-2.93pp
2016-12-31	-0.01%	CN¥-69.38K ≈ $-10.15K	CN¥1.01 Billion ≈ $147.17 Million	+0.00pp
2015-12-31	-0.01%	CN¥-60.83K ≈ $-8.90K	CN¥798.57 Million ≈ $116.86 Million	--

pp = percentage points

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices

Market Cap

$1.21 Billion

CN¥8.26 Billion CNY

Market Cap Rank

#8002 Global

#1791 in China

Share Price

CN¥17.64

Change (1 day)

+1.15%

52-Week Range

CN¥15.69 - CN¥25.56

All Time High

CN¥92.01